Medication abortion with mifepristone and vaginal misoprostol between 64 and 70 days’ gestation
Awarded 2017
Complex Family Planning Fellowship Research
Jennifer Hsia , MD, MPH
University of California, Davis

This is a retrospective cohort study evaluating the effectiveness of early medication abortion between 64-70 days gestation in the UK using a mifepristone and vaginal misoprostol regimen. This study will be performed in collaboration with BPAS, whose abortion data specifically for this gestational age is impressive, with over 2700 cases of early medication abortion. This study will help determine the effectiveness with larger numbers than previously described in the literature.